2400260 Part 1 - Cohort A, B, D, E (SAD)
Study to treat psoriasis and inflammatory bowel diseases
25-60
- Male
> 7 days
1
Compensation provided
Are you
- a healthy man
- between 25 and 60 years old (inclusive)
- with a BMI between 18.5kg and 30.0kg/m² (inclusive)
- who does not smoke or has stopped smoking at least 6 months before admission
- and does not use daily medication
What does this study invlove?
In study 2400260 Cohort A, B, D and E, SGS CPU is investigating the treatment of psoriasis and inflammatory bowel diseases. The study lasts +/- 5 weeks with the following contact moments:
- a screening visit
- a stay of 6 days (5 overnight stays)
- a visit discharge
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
